Skip to content
Riskpilot
← Back to search
Sign in
Get full access
FERRING PHARMACEUTICALS A/S
A/S
Active
CVR 16313440
Amager Strandvej 405, 2770
Kastrup
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 1992 · 33 years old
567 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
FERRING PHARMACEUTICALS A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
486M
972M
1B
2B
1.1B
2020
1.0B
2021
1.3B
2022
1.5B
2023
1.7B
2024
EBITDA
DKK millions
166M
125M
83M
42M
0M
75M
2020
54M
-28%
2021
98M
+81%
2022
118M
+20%
2023
133M
+13%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Revenue
1.051.468
1.005.468
1.261.432
1.457.509
1.690.294
Staff expenses
-0
-145.824
-548.186
-589.536
-677.285
EBITDA
75.226
54.035
97.748
118.185
133.251
Depreciation & amort.
-18.679
-0
-31.208
-29.229
-30.089
EBIT
56.547
54.035
66.540
88.956
103.162
Net financials
-3.796
-1.976
-2.595
-2.721
-4.190
Profit before tax
52.751
52.059
63.945
86.235
98.972
Tax
11.823
11.885
11.568
19.125
22.082
Net profit
40.928
40.174
52.377
67.110
76.890
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
381.839
472.880
485.671
586.405
554.485
Equity
79.444
69.618
121.995
189.325
266.214
Long-term debt
0
125.000
100.000
75.000
0
Short-term debt
294.410
269.084
255.819
315.813
282.477
Total debt
294.410
394.084
355.819
390.813
282.477
Financial ratios
5-year trend
EBITDA margin
7.9%
This company
15.8%
Market median
-50% vs market
2020
2024
Equity ratio
48.0%
This company
38.2%
Market median
+26% vs market
2020
2024
Return on equity
28.9%
This company
18.4%
Market median
+57% vs market
2020
2024
Net profit margin
4.5%
This company
8.1%
Market median
-44% vs market
2020
2024
Asset turnover
3.05×
This company
1.12×
Market median
+172% vs market
2020
2024
Debt / equity
1.08×
This company
0.62×
Market median
-74% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on FERRING PHARMACEUTICALS A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
